BillionToOne Launches Northstar Origin Liquid Biopsy Test
Menlo Park, California, USA, September 1, 2026 BillionToOne has launched Northstar Origin™, a new liquid biopsy add-on test designed...
cardiac surgery
Advertisement
CytoSorbents Advances DrugSorb-ATR FDA Regulatory Path
Princeton, New Jersey, USA, September 2, 2026 CytoSorbents Corporation has announced new real-world clinical data showing that use of...
Arch Biopartners Gains U.S. IRB Approval for LSALT Phase II
TORONTO, Canada, August 31, 2026 Arch Biopartners Inc. announced that it has received central Institutional Review Board (IRB) approval...
Arch Biopartners Expands LSALT Peptide Phase 2 Kidney Injury Trial to U.S.
TORONTO, Canada, August 11, 2026 Arch Biopartners Inc. announced plans to expand its ongoing Phase 2 clinical trial of...
Total Flow Medical TFA Cannula Secures FDA 510(k) Clearance
VANCOUVER, BC, July 30, 2026 Total Flow Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Advertisements
Arch Biopartners Advances Phase II AKI Trial
TORONTO, May 22, 2026 Arch Biopartners announced that Royal Columbian Hospital (RCH) in British Columbia has dosed its first...
Renibus Reports Phase 3 RBT-1 Data at AATS Meeting
SOUTHLAKE, TEXAS, April 30, 2026 Renibus Therapeutics has announced the oral presentation of Phase 3 PROTECT trial data for...
Cincinnati Children’s Expands Pediatric Heart Care US
February 24, 2026 – Cincinnati, Ohio & Tacoma, Washington, USA Cincinnati Children’s Hospital Medical Center has announced a strategic...
Artificial Heart Bridge Enables Successful Transplant
TUCSON, Ariz., Feb. 12, 2026 — Picard Medical, parent company of SynCardia Systems, announced a landmark bridge-to-transplant milestone at...
Arch Biopartners Expands Phase II Kidney Injury Trial in Canada
TORONTO, November 5, 2025 — Arch Biopartners Inc. (TSXV: ARCH, OTCQB: ACHFF) announced that the Fraser Health Research Ethics...
Advertisement
